Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janice P Dutcher

Showing results (1-10 of 90) with videos related to

Pageof 9
Sort By:
Oncology (Williston Park, N.Y.)|December 10, 2002
Current status of interleukin-2 therapy for metastatic renal cell carcinoma and metastatic melanomaJanice P Dutcher
Current Oncology Reports|January 31, 2004
Mammalian target of rapamycin (mTOR) InhibitorsJanice P Dutcher
Leukemia Research|March 22, 2003
The role of Epstein-Barr virus and elevated levels of tumor necrosis factor in determining prognosis in Asian peripheral T-cell lymphomasJanice P Dutcher
Therapeutic Advances in Urology|December 3, 2013
Recent developments in the treatment of renal cell carcinomaJanice P Dutcher
Cancer Treatment and Research|December 4, 2003
Interleukin-2 based therapy for kidney cancerJanice P Dutcher
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2004
Mammalian target of rapamycin inhibitionJanice P Dutcher
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|November 21, 2018
Update on the biology and management of renal cell carcinomaJanice P Dutcher
American Journal of Therapeutics|August 1, 1994
A Review of the New Cytokines: IL-4, IL-6, IL-11, and IL-12Leslie Oleksowicz, Janice P. Dutcher
Medical Oncology (Northwood, London, England)|August 19, 2010
Long-term survival of patients with sarcomatoid renal cell cancer treated with chemotherapyJanice P Dutcher, David Nanus
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|October 21, 2023
Families with non-Hodgkin lymphoma and plasma cell dyscrasias in their pedigreesPeter H Wiernik, Janice P Dutcher
Pageof 9

Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
Oncology (Williston Park, N.Y.)|December 10, 2002
Current status of interleukin-2 therapy for metastatic renal cell carcinoma and metastatic melanomaJanice P Dutcher
Current Oncology Reports|January 31, 2004
Mammalian target of rapamycin (mTOR) InhibitorsJanice P Dutcher
Leukemia Research|March 22, 2003
The role of Epstein-Barr virus and elevated levels of tumor necrosis factor in determining prognosis in Asian peripheral T-cell lymphomasJanice P Dutcher
Therapeutic Advances in Urology|December 3, 2013
Recent developments in the treatment of renal cell carcinomaJanice P Dutcher
Cancer Treatment and Research|December 4, 2003
Interleukin-2 based therapy for kidney cancerJanice P Dutcher
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2004
Mammalian target of rapamycin inhibitionJanice P Dutcher
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|November 21, 2018
Update on the biology and management of renal cell carcinomaJanice P Dutcher
American Journal of Therapeutics|August 1, 1994
A Review of the New Cytokines: IL-4, IL-6, IL-11, and IL-12Leslie Oleksowicz, Janice P. Dutcher
Medical Oncology (Northwood, London, England)|August 19, 2010
Long-term survival of patients with sarcomatoid renal cell cancer treated with chemotherapyJanice P Dutcher, David Nanus
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|October 21, 2023
Families with non-Hodgkin lymphoma and plasma cell dyscrasias in their pedigreesPeter H Wiernik, Janice P Dutcher
Pageof 9